Close Menu

NEW YORK (GenomeWeb) – Neural cells derived from human induced pluripotent stem cells can give insight into what drugs might treat schizophrenia, according to a new study.

Current drugs to treat people with schizophrenia are only effective in a portion of patients, as about two-thirds either don't respond to treatment or only partially respond. However, a lack of models has limited the ability to develop new therapies, the authors of the new study said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The editorial board of the Pittsburgh Post-Gazette says other lawmakers should take Florida's approach and provide additional protections against genetic discrimination.

The Hill reports 17 states and the District of Columbia are suing over a new policy that would strip international students of their visas if they only attend classes online.

Centers for Disease Control and Prevention employees call on the agency to label racism a public health crisis and examine its own policies, NPR reports.

In PNAS this week: genetic evidence for Inca resettlement, analysis of spermatogonial stem cell transcriptomes, and more.

Aug
27
Sponsored by
Cellecta

Over 70 percent of breast cancers are estrogen receptor positive and are treated with endocrine therapy.